ProPublica

Journalism in the Public Interest

Cancel

General Electric’s Comments to our Omniscan Stories—and Our Response

GE Healthcare has posted several comments criticizing our stories about MRI patients who developed a crippling disease after using the company's MRI drug, Omniscan. We encourage feedback and have responded to company spokesman Jeff DeMarrais. See our comments at "GE’s Own Safety Team Urged Company to Restrict MRI Drug" (comments) and "Judge Opens Door to Case Against General Electric’s Omniscan" (comments).

Get Updates

Stay on top of what we’re working on by subscribing to our email digest.

optional